

Author: Lindauer Andreas
Publisher: Adis International
ISSN: 0312-5963
Source: Clinical Pharmacokinetics, Vol.47, Iss.11, 2008-01, pp. : 721-731
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




Biomarkers, Validation and Pharmacokinetic-Pharmacodynamic Modelling
By Colburn W.A.
Clinical Pharmacokinetics, Vol. 42, Iss. 12, 2003-01 ,pp. :




Methodological Issues in Pharmacokinetic-Pharmacodynamic Modelling
Clinical Pharmacokinetics, Vol. 35, Iss. 2, 1998-08 ,pp. :